About this trial
Last updated 2 years ago
Study ID
Status
Type
Phase
Placebo
Accepting
Not accepting
Trial Timing
Ended 2 years ago
What is this trial about?
What are the participation requirements?
Inclusion Criteria
- Clinical stability, evaluated through the administration of the MEWS scale (Modified Early Warning Score);
- To be able to stand up from a chair without exceeding a trunk angle of 45° to the left or right during the movement;
- To be able to walk for 10 m without the support of another person but, if necessary, with conventional aids different than knee othesis (e.g. stick, crutch, ankle/foot orthesis). The aid considered should have single-support;
- Height between 150 cm and 195 cm;
- Weight between 45 kg and 110 kg;
- FAC (Functional Ambulation Calssification) ≥3;
- MAS (Modified Ashworth Scale) ≤2;
- HADS (Hospital Anxiety and Depression Scale) with normative values (>10/21 for each scale);
- MoCA (Montreal Cognitive Assessment) (Equivalent scoring > 1 with the Italian correction from Santangelo et al._ 2015);
- To be able to understand and sign the informed consent.
Exclusion Criteria
- Presence of an active (or with effects) neurological or psychiatric pathology occurred before the vascular event;
- Severe bilateral hearing or sight loss;
- Functional Reach Test <15.24;
- Flexion retruction of hip and knee greater than 10° and not reducible;
- Presence of genu varum or geru valgum greater than 10°;
- Pregnancy;
- Previous stroke.